Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review-Reference-Cited by-同舟云学术

Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review

Published:2021-03 Issue:2 Volume:11 Page:e203-e209
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Wong Jordan^ORCID,Pickles Tom,Connors Joseph,Aquino-Parsons Christina,Sehn Laurie,Freeman Ciara,DeVries Kim,Lo Andrea^ORCID

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Epidemiology of non-Hodgkin’s lymphoma (NHL): Trends, geographic distribution, and etiology;Müller;Ann Hematol,2005

2. Radiation therapy for diffuse large B-cell lymphoma: Indications, outcomes, and controversies;Pinnix;Int J Radiat Oncol,2016

3. Re-examining the role of radiation therapy for diffuse large B-cell lymphoma in the modern era;Ng;J Clin Oncol,2016

4. Role of radiation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group;Ng;Int J Radiat Oncol Biol Phys,2018

5. Relapsed/refractory diffuse large B-cell lymphoma;Friedberg;Hematology Am Soc Hematol Educ Program,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma;Practical Radiation Oncology;2024-09

2. Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy;Haematologica;2023-06-15

3. Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?;Advances in Radiation Oncology;2022-11

4. Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy;Radiotherapy and Oncology;2022-10

5. Highly favorable outcomes with salvage radiation therapy and autologous hematopoietic cell transplantation in relapsed and refractory DLBCL patients with minimal to no response to salvage chemotherapy;Bone Marrow Transplantation;2022-04-16